期刊
DIALOGUES IN CLINICAL NEUROSCIENCE
卷 22, 期 3, 页码 223-228出版社
INST CONFERENCE HIPPOCRATE
DOI: 10.31887/DCNS.2020.22.3/mcrocq
关键词
anandamide; cannabis; endocannabinoid; hashish; history; marijuana; Mechoulam; Moreau de Tours; Silvestre de Sacy; tetrahydrocannabinol; William Brooke O'Shaughnessy
This article retraces the story of cannabis from the earliest contacts of humans with the plant to its subsequent global expansion, its medicinal uses, and the discovery of the endocannabinoid system in the 20th century. Cannabis was attested to around 12 000 years ago near the Altai Mountains in Central Asia, and since then, cannabis seeds have accompanied the migration of nomadic peoples. Records of the medicinal use of cannabis appear before the Common Era in China, Egypt, and Greece (Herodotus), and later in the Roman empire (Pliny the Elder, Dioscorides, Galen). In the 19th century, orientalists like Silvestre de Sacy, and Western physicians coming into contact with Muslim and Indian cultures, like O'Shaughnessy and Moreau de Tours, introduced the medicinal use of cannabis into Europe. The structure of the main psychoactive phytocannabinoid, tetrahydrocannabinol (THC), was determined in Israel by Mechoulam and Gaoni in 1964. This discovery opened the gate for many of the subsequent developments in the field of endocannabinoid system (ECS) research. The advances in the scientific knowledge of the ECS place the debate on cannabis liberalization in a new context. (C) 2020, AICH - Servier Group
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据